Doctor Dennis Kannenkeril
University Hospital Erlangen, Erlangen (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease
Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session: Lipid-lowering by PCSK9 modulation: what’s new?
ESC 365 is supported by
